An observational study in Renal Disease and High Blood Pressure, sponsored by Renal Research Institute. Completed at 1 site in United States. Open to participants aged 18 Years to 88 Years. Per ClinicalTrials.gov, last updated 2015-05-05.
Sponsored by Renal Research Institute · Observational
Hyper- and hypotension are important predictors of survival in non-ESRD (end stage renal disease) population. In dialysis patients, however, it has been shown that higher blood pressure levels may actually be beneficial to patient outcomes. Dynamics of blood pressure evolution over time has not been previously studied in dialysis population. The investigators aim to understand how both blood pressure levels and blood pressure changes over time predict patient survival.
6,689 studies on the registry are indexed under Hypertension; 965 are open to participants now.
This study's enrollment of 12,695 is above the median of 210 across 1,359 observational studies indexed under Hypertension.
Browse Hypertension studies →Renal Research Institute is the lead sponsor of 18 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Renal Research Institute hemodialysis patients
Inclusion Criteria:
Effect size of the relation of dynamic changes of blood pressure (BP) at different ranges of BP to survival in incident hemodialysis patients.
The ranges of blood pressure measurements in mmHg over time and the relation to patient outcomes (including survival)
Time frame: Up to 11 years and 11 months
This study is completed, as verified in May 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Renal Research Institute